Q linea AB
F:3F8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Q linea AB
F:3F8
|
SE |
|
N
|
Netum Group Oyj
F:79J
|
FI |
|
C
|
CACI International Inc
F:CA8A
|
US |
|
V
|
Volatus Aerospace Inc
XMUN:ABB
|
CA |
|
K
|
Kilroy Realty Corp
F:KRC
|
US |
|
Dermapharm Holding SE
OTC:DMPHF
|
DE |
|
H2APEX Group SCA
F:H2A
|
LU |
|
H
|
Hormel Foods Corp
DUS:HO7
|
US |
|
STINAG Stuttgart Invest AG
F:STG
|
DE |
Wall St Price Targets
3F8 Price Targets Summary
Q linea AB
According to Wall Street analysts, the average 1-year price target for
3F8 is 10.59 EUR with a low forecast of 10.49 EUR and a high forecast of 10.9 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3F8's stock price target?
Price Target
10.59
EUR
According to Wall Street analysts, the average 1-year price target for
3F8 is 10.59 EUR with a low forecast of 10.49 EUR and a high forecast of 10.9 EUR.
What is the Revenue forecast for Q linea AB?
Projected CAGR
218%
Over the last 7 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 3 years is 218%.